Abstract
In light of the COVID-19 pandemic, the Medicines and Healthcare products Regulatory Agency administered the standards for producing a Rapidly Manufactured Ventilator System (RMVS) free of charge due to the United Kingdom’s shortfall of ventilator systems throughout health centers. The standards delineate the minimum requirements in which a Rapidly Manufactured Ventilator System must encompass to be admissible for usage within hospitals. This work commences by evaluating the standards provided by the government to identify any potential security vulnerabilities that may arise due to the succinct development standards provided by the MHRA. This research investigates what cyber considerations are taken to safeguard a patient’s health and medical data to improve situational awareness. A tool for a remotely accessible, low-cost ventilator system is developed to reveal what a malicious actor may be able to inflict on a modern ventilator and its adverse impact.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have